Big Pharma is again raising the prices for key medications that could save the lives of millions in Georgia and there are still more hikes to come.

Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has been approved for chronic kidney disease in the EU - the first major market to clear the new use for the drug. Adding CKD to the ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

President Donald Trump has been accused of raising prescription drug prices for seniors by immediately rescinding former President Joe Biden's executive order to lower costs after beginning his ...

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

Among the dozens of Biden-era executive orders he rescinded on day one, President Trump nixed one that aimed to explore new health care payment models that would lower prescription costs for ...

The majority of Americans think prescription drug costs are unreasonable and believe a major contributor to the high cost is profits made by pharmaceutical companies, a survey by KFF found.

Cancer drug prices are soaring, but they don't reflect improvements in patient survival. Instead, prices are often based on market size, not therapeutic value. The cost of cancer drugs paid by ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

Medicare plans to negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities.

When big pharmaceutical companies merge, the perception is that drug prices rise, but a University of Iowa study finds that’s not always the case. Study co-author Amrita Nain, a professor of ...